Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Stephens

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
European Urology|February 21, 2016
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic AlterationsGabriel G Malouf, Siraj M Ali, Kai Wang, et al.
Cancer|January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
The Oncologist|August 16, 2018
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation BurdenWinnie S Liang, Jo-Anne Vergilio, Bodour Salhia, et al.
Cancer Discovery|July 29, 2015
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101Robert C Doebele, Lara E Davis, Aria Vaishnavi, et al.
JAMA Oncology|July 17, 2015
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted TherapiesJeffrey S Ross, Kai Wang, Laurie Gay, et al.
International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.
British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.
Oncotarget|June 15, 2018
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profilingKatherine Tarlock, Shan Zhong, Yuting He, et al.
Cell Reports|May 13, 2014
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
European Urology|February 21, 2016
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic AlterationsGabriel G Malouf, Siraj M Ali, Kai Wang, et al.
Cancer|January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
The Oncologist|August 16, 2018
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation BurdenWinnie S Liang, Jo-Anne Vergilio, Bodour Salhia, et al.
Cancer Discovery|July 29, 2015
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101Robert C Doebele, Lara E Davis, Aria Vaishnavi, et al.
JAMA Oncology|July 17, 2015
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted TherapiesJeffrey S Ross, Kai Wang, Laurie Gay, et al.
International Journal of Cancer|August 29, 2015
The distribution of BRAF gene fusions in solid tumors and response to targeted therapyJeffrey S Ross, Kai Wang, Juliann Chmielecki, et al.
British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.
Oncotarget|June 15, 2018
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profilingKatherine Tarlock, Shan Zhong, Yuting He, et al.
Cell Reports|May 13, 2014
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, et al.
Pageof 17